MedTrace Logo

Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study

NCT00460213 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2013-12-09

No results posted yet for this study

Summary

The purpose of this study is to compare improvement percentage of urinary albumin excretion between valsartan 80 mg- and valsartan 160 mg-based therapy in patient with morning hypertension.

Conditions

Interventions

DRUG

Valsartan 80mg daily

DRUG

Valsartan 160mg daily

Sponsors & Collaborators

  • Kitakyushu-Tsuyazaki Hospital

    lead OTHER

Principal Investigators

  • Koshiro Fukiyama, MD · Japan Seamen's Relief Association Moji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2008-12-31
Completion
2013-11-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00460213 on ClinicalTrials.gov